Dishman Carbogen Amcis Limited (DCAL.NS)
Dishman Carbogen Amcis Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Ahmedabad, GU, IN. The stock last traded at $190.66, down 3.95% on the session, giving a market capitalisation of $29.89B. Its beta of 0.62 implies it has historically moved less than the broad market.
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes, sanitizers, and antiseptics, as well as a range of pharmaceutical and cosmetic formulations, including generic and highly potent active pharmaceutical ingredients. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Dishman Carbogen Amcis Limited is most often compared with the following Healthcare names: